JP6369551B2 - 粒子を送達する装置 - Google Patents
粒子を送達する装置 Download PDFInfo
- Publication number
- JP6369551B2 JP6369551B2 JP2016547946A JP2016547946A JP6369551B2 JP 6369551 B2 JP6369551 B2 JP 6369551B2 JP 2016547946 A JP2016547946 A JP 2016547946A JP 2016547946 A JP2016547946 A JP 2016547946A JP 6369551 B2 JP6369551 B2 JP 6369551B2
- Authority
- JP
- Japan
- Prior art keywords
- cassette
- silencer
- particles
- button
- cylinder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002245 particle Substances 0.000 title claims description 73
- 230000003584 silencer Effects 0.000 claims description 94
- 239000012528 membrane Substances 0.000 claims description 31
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 24
- 239000005038 ethylene vinyl acetate Substances 0.000 claims description 17
- 229920000515 polycarbonate Polymers 0.000 claims description 13
- 239000004417 polycarbonate Substances 0.000 claims description 13
- 239000004696 Poly ether ether ketone Substances 0.000 claims description 6
- 229920002530 polyetherether ketone Polymers 0.000 claims description 6
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 6
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 6
- -1 polyethylene terephthalate Polymers 0.000 claims description 4
- 239000007789 gas Substances 0.000 description 86
- 238000012856 packing Methods 0.000 description 32
- 238000000034 method Methods 0.000 description 16
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 12
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 12
- 229920000642 polymer Polymers 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 239000006260 foam Substances 0.000 description 10
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 229940088679 drug related substance Drugs 0.000 description 5
- 239000004793 Polystyrene Substances 0.000 description 4
- 239000008186 active pharmaceutical agent Substances 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 229940124597 therapeutic agent Drugs 0.000 description 4
- 230000037317 transdermal delivery Effects 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000000994 depressogenic effect Effects 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 229920005669 high impact polystyrene Polymers 0.000 description 3
- 239000004797 high-impact polystyrene Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 229940126534 drug product Drugs 0.000 description 2
- 229920001038 ethylene copolymer Polymers 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229960004194 lidocaine Drugs 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229920006289 polycarbonate film Polymers 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 229920003031 santoprene Polymers 0.000 description 2
- 239000008259 solid foam Substances 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
- 206010069803 Injury associated with device Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013271 transdermal drug delivery Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
- A61M5/3015—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules for injecting a dose of particles in form of powdered drug, e.g. mounted on a rupturable membrane and accelerated by a gaseous shock wave or supersonic gas flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M2005/14513—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons with secondary fluid driving or regulating the infusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M2005/2073—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically preventing premature release, e.g. by making use of a safety lock
- A61M2005/208—Release is possible only when device is pushed against the skin, e.g. using a trigger which is blocked or inactive when the device is not pushed against the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/12—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/42—Reducing noise
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
- A61M5/3007—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules with specially designed jet passages at the injector's distal end
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Filling Or Discharging Of Gas Storage Vessels (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Description
Claims (9)
- 粒子を送達する装置であって、前記装置は、前記粒子を内部に蓄える粒子カセットと圧縮ガス容器を備え、
前記粒子カセットはカセットハウジング及びカセット膜を有し、前記カセットハウジングは、酢酸ビニル(VA)が18%〜28%のエチレン酢酸ビニル(EVA)共重合体を含み、
前記圧縮ガス容器は圧縮ガスを前記粒子カセットの外部に送出して前記圧縮ガスで前記カセット膜を裂開し、前記粒子は前記圧縮ガスによって加速されて前記粒子カセットから外に出て、前記粒子の40%超が、前記圧縮ガスによって送達され、
前記カセット膜は、ポリカーボネート、ポリエチレンテレフタレート、およびポリエーテルエーテルケトンから構成され、それぞれの構成比は1:1:1である、装置。 - 前記粒子の70%超が、前記圧縮ガスによって送達される、請求項1に記載の装置。
- 前記粒子の40〜85%が、前記圧縮ガスによって送達される、請求項1に記載の装置。
- 前記粒子の60〜85%が、前記圧縮ガスによって送達される、請求項1に記載の装置。
- 前記カセット膜は、厚さ10〜13ミクロンである、請求項1に記載の装置。
- さらに、前記装置の意図しないトリガの作動のリスクを低減するための安全インターロックを備える、請求項1に記載の装置。
- さらに消音装置を備え、圧縮ガスによって加速されて前記粒子カセットから外に出る粒子が前記消音装置を通って外に出る、請求項1に記載の装置。
- 前記カセットハウジングのエチレン酢酸ビニル(EVA)共重合体が18%〜20%の酢酸ビニル(VA)を含む、請求項1に記載の装置。
- 前記カセットハウジングのエチレン酢酸ビニル(EVA)共重合体が18%の酢酸ビニル(VA)を含む、請求項1に記載の装置。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461945021P | 2014-02-26 | 2014-02-26 | |
US61/945,021 | 2014-02-26 | ||
PCT/US2015/017816 WO2015130961A1 (en) | 2014-02-26 | 2015-02-26 | Device for delivering particles |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017524384A JP2017524384A (ja) | 2017-08-31 |
JP6369551B2 true JP6369551B2 (ja) | 2018-08-08 |
Family
ID=54009626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016547946A Expired - Fee Related JP6369551B2 (ja) | 2014-02-26 | 2015-02-26 | 粒子を送達する装置 |
Country Status (9)
Country | Link |
---|---|
US (5) | US9370622B2 (ja) |
EP (1) | EP3110404A4 (ja) |
JP (1) | JP6369551B2 (ja) |
KR (1) | KR101845648B1 (ja) |
CN (2) | CN106163500A (ja) |
AU (1) | AU2015222937B2 (ja) |
SG (2) | SG11201606034WA (ja) |
TW (1) | TWI689323B (ja) |
WO (1) | WO2015130961A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106163500A (zh) | 2014-02-26 | 2016-11-23 | 普乐药业有限公司 | 用于递送颗粒的装置 |
US11484441B2 (en) * | 2016-04-29 | 2022-11-01 | Bausch & Lomb Incorporated | Ultrasonic surgical aspiration needle assembly with molded hub |
US11752269B2 (en) * | 2019-12-18 | 2023-09-12 | Integrimedical Llc | Spring loaded medical needle-free injection system |
US20240075265A1 (en) * | 2022-09-07 | 2024-03-07 | Particle Vaccine Canada Ltd. | Method and apparatus for epidermal delivery of powdered medicaments |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2680439A (en) * | 1948-09-08 | 1954-06-08 | Arnold K Sutermeister | High-pressure injection device |
CA1093728A (en) * | 1976-11-10 | 1981-01-13 | Gary L. Stutzman | Thermosetting compositions for injection molding |
JPS56143040U (ja) * | 1980-03-27 | 1981-10-28 | ||
US4913699A (en) | 1988-03-14 | 1990-04-03 | Parsons James S | Disposable needleless injection system |
US4983171A (en) * | 1989-07-14 | 1991-01-08 | W. R. Grace & Co.-Conn. | Comfortable ostomy pouch |
US5312335A (en) * | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
KR910011852A (ko) * | 1989-12-04 | 1991-08-07 | 폴 디. 매튜카이티스 | 신경독 장해 치료용 이미다조[1,2-a]피리디닐알킬 화합물 |
US5472021A (en) * | 1993-02-05 | 1995-12-05 | Innostar, Inc. | Nonspill bottled water replacement system with disposable seal member |
TW360548B (en) * | 1993-04-08 | 1999-06-11 | Powderject Res Ltd | Products for therapeutic use |
US5899880A (en) * | 1994-04-08 | 1999-05-04 | Powderject Research Limited | Needleless syringe using supersonic gas flow for particle delivery |
JP2719890B2 (ja) * | 1994-09-16 | 1998-02-25 | 株式会社ユタカ技研 | 消音器 |
GB9605690D0 (en) * | 1996-03-19 | 1996-05-22 | Oxford Biosciences Ltd | Particle delivery |
EP0907718B1 (en) * | 1996-06-14 | 2004-12-29 | Powderject Vaccines, Inc. | Sample delivery module for particle acceleration apparatus |
EP0888790A1 (en) * | 1997-07-04 | 1999-01-07 | PowderJect Research Limited | Drug particle delivery device |
US6328714B1 (en) * | 1999-01-29 | 2001-12-11 | Powderject Research Limited | Particle delivery device |
US6849060B1 (en) * | 1999-01-29 | 2005-02-01 | Powderject Research Limited | Particle delivery device |
GB9905933D0 (en) * | 1999-03-15 | 1999-05-05 | Powderject Res Ltd | Neeedleless syringe |
US6797737B1 (en) * | 1999-07-01 | 2004-09-28 | E. I. Du Pont De Nemours And Company | Crosslinked foam of ethylene vinyl acetate copolymer and acid copolymer |
US6210359B1 (en) * | 2000-01-21 | 2001-04-03 | Jet Medica, L.L.C. | Needleless syringe |
GB0100756D0 (en) * | 2001-01-11 | 2001-02-21 | Powderject Res Ltd | Needleless syringe |
DE10108900B4 (de) | 2001-02-23 | 2005-03-10 | 3M Espe Ag | Ermittlung des patientenbezogenen Kariesrisikos |
EP1399131A2 (en) * | 2001-06-08 | 2004-03-24 | Powderject Vaccines, Inc. | Spray freeze-dried compositions |
WO2003011379A1 (en) * | 2001-07-26 | 2003-02-13 | Powderject Research Limited | Particle cassette, method and kit therefor |
US20030019558A1 (en) * | 2001-07-26 | 2003-01-30 | Smith Edward R. | Particle cassette, method and kit therefor |
GB0118266D0 (en) * | 2001-07-26 | 2001-09-19 | Powderject Res Ltd | Silencing device and method for needleless syringe |
US8061006B2 (en) * | 2001-07-26 | 2011-11-22 | Powderject Research Limited | Particle cassette, method and kit therefor |
CN1268263C (zh) * | 2004-11-29 | 2006-08-09 | 山东九阳小家电有限公司 | 易清洗多功能豆浆机 |
US20060112998A1 (en) * | 2004-12-01 | 2006-06-01 | Tekni-Plex, Inc. | Multi-layered hose |
GB0611443D0 (en) * | 2006-06-09 | 2006-07-19 | Powderject Res Ltd | Improvements in, or relating to, particle cassettes |
CN100446823C (zh) * | 2006-09-19 | 2008-12-31 | 宁波新芝生物科技股份有限公司 | 一种无创介入治疗系统 |
US7516690B2 (en) * | 2006-12-22 | 2009-04-14 | Mcclellan W Thomas | Firearm suppressor, mounting system and mounting method |
GB0708758D0 (en) | 2007-05-04 | 2007-06-13 | Powderject Res Ltd | Particle cassettes and process thereof |
ITMI20081315A1 (it) * | 2008-07-18 | 2010-01-19 | Iph Establishment | Dispositivo per rimuovere secrezioni polmonari |
EP2158927A1 (en) * | 2008-08-25 | 2010-03-03 | Debiotech S.A. | Drug delivery device with a module for preventing fibrillation downstream of its reservoir |
US8827946B2 (en) * | 2009-07-31 | 2014-09-09 | Shin Nippon Biomedical Laboratories, Ltd. | Intranasal granisetron and nasal applicator |
EP2552349A4 (en) * | 2010-03-31 | 2017-12-06 | Ocuject, LLC | Device and method for intraocular drug delivery |
SI2600930T1 (sl) * | 2010-08-05 | 2021-08-31 | Forsight Vision4, Inc. | Injekcijska naprava za dajanje zdravila |
EP2782485B1 (en) * | 2011-09-09 | 2018-10-24 | Fountain Master, LLC | Beverage maker |
CN103792603B (zh) * | 2012-10-26 | 2016-07-06 | 3M创新有限公司 | 回归反射材料及制品 |
NO335475B1 (no) * | 2013-03-08 | 2014-12-15 | A Tec Holding As | Lyddemper for skytevåpen |
CN106163500A (zh) | 2014-02-26 | 2016-11-23 | 普乐药业有限公司 | 用于递送颗粒的装置 |
-
2015
- 2015-02-26 CN CN201580010583.9A patent/CN106163500A/zh active Pending
- 2015-02-26 SG SG11201606034WA patent/SG11201606034WA/en unknown
- 2015-02-26 WO PCT/US2015/017816 patent/WO2015130961A1/en active Application Filing
- 2015-02-26 KR KR1020167026375A patent/KR101845648B1/ko active IP Right Grant
- 2015-02-26 JP JP2016547946A patent/JP6369551B2/ja not_active Expired - Fee Related
- 2015-02-26 TW TW104106444A patent/TWI689323B/zh active
- 2015-02-26 AU AU2015222937A patent/AU2015222937B2/en not_active Ceased
- 2015-02-26 SG SG10201909400R patent/SG10201909400RA/en unknown
- 2015-02-26 CN CN201611102430.XA patent/CN106975128B/zh active Active
- 2015-02-26 EP EP15754729.0A patent/EP3110404A4/en not_active Withdrawn
- 2015-09-29 US US14/869,670 patent/US9370622B2/en not_active Expired - Fee Related
- 2015-10-01 US US14/873,054 patent/US10071204B2/en not_active Expired - Fee Related
- 2015-10-01 US US14/873,028 patent/US10384011B2/en not_active Expired - Fee Related
-
2016
- 2016-03-22 US US15/077,753 patent/US10384012B2/en not_active Expired - Fee Related
-
2019
- 2019-08-20 US US16/545,933 patent/US20190366003A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US9370622B2 (en) | 2016-06-21 |
WO2015130961A1 (en) | 2015-09-03 |
CN106163500A (zh) | 2016-11-23 |
TW201540331A (zh) | 2015-11-01 |
KR20160141717A (ko) | 2016-12-09 |
US20160199580A1 (en) | 2016-07-14 |
US20190366003A1 (en) | 2019-12-05 |
CN106975128B (zh) | 2021-02-26 |
US20160038681A1 (en) | 2016-02-11 |
US10384012B2 (en) | 2019-08-20 |
AU2015222937B2 (en) | 2017-03-30 |
CN106975128A (zh) | 2017-07-25 |
US20160022910A1 (en) | 2016-01-28 |
AU2015222937A1 (en) | 2016-10-13 |
JP2017524384A (ja) | 2017-08-31 |
SG11201606034WA (en) | 2016-09-29 |
KR101845648B1 (ko) | 2018-04-04 |
SG10201909400RA (en) | 2019-11-28 |
TWI689323B (zh) | 2020-04-01 |
US10071204B2 (en) | 2018-09-11 |
EP3110404A1 (en) | 2017-01-04 |
EP3110404A4 (en) | 2018-03-14 |
US10384011B2 (en) | 2019-08-20 |
US20160022911A1 (en) | 2016-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11696984B2 (en) | Therapeutic agents for delivery using a catheter and pressure source | |
JP6369551B2 (ja) | 粒子を送達する装置 | |
FI120671B (fi) | Hiukkasten siirrossa yliäänikaasuvirtausta käyttävä neulaton injektioruisku | |
KR102557768B1 (ko) | 재구성 가능 작용제로 미리 충진된 일회용 전달 장치 | |
KR100702653B1 (ko) | 바늘없는 주사장치와 이로부터 입자를 배출하는 방법 | |
US20240075265A1 (en) | Method and apparatus for epidermal delivery of powdered medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160906 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170131 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20170131 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170124 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170310 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20170310 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20170310 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170327 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20170529 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170531 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170627 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170926 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171227 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171227 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20171227 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180313 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180511 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180529 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180625 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6369551 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |